| 1 |
25733728 | Effect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues. | 2016 Jan |
1 |
| 2 |
25304971 | Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats. | 2015 May |
1 |
| 3 |
23376209 | Role of recombinant human erythropoietin in mitomycin C-induced genotoxicity: analysis of DNA fragmentation, chromosome aberrations and micronuclei in rat bone-marrow cells. | 2013 Apr 30 |
1 |
| 4 |
23970409 | Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: cisplatin and mitomycin C in cultured Vero cells. | 2013 Aug 1 |
1 |
| 5 |
22233822 | Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapy. | 2011 Dec |
3 |
| 6 |
20551641 | In vitro and in vivo cytogenetic effects of recombinant human erythropoietin on the frequency of sister chromatid exchanges alone or in combination with mitomycin C. | 2010 |
2 |
| 7 |
12053072 | Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome. | 2002 Jun |
1 |
| 8 |
7917560 | Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen. | 1994 |
1 |